Annual D&A
$2.90 M
-$417.00 K-12.59%
December 31, 2024
Summary
- As of March 12, 2025, PTGX annual depreciation & amortization is $2.90 million, with the most recent change of -$417.00 thousand (-12.59%) on December 31, 2024.
- During the last 3 years, PTGX annual D&A has risen by +$120.00 thousand (+4.32%).
- PTGX annual D&A is now -14.07% below its all-time high of $3.37 million, reached on December 31, 2022.
Performance
PTGX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$536.00 K
-$111.00 K-17.16%
December 31, 2024
Summary
- As of March 12, 2025, PTGX quarterly depreciation & amortization is $536.00 thousand, with the most recent change of -$111.00 thousand (-17.16%) on December 31, 2024.
- Over the past year, PTGX quarterly D&A has dropped by -$111.00 thousand (-17.16%).
- PTGX quarterly D&A is now -39.91% below its all-time high of $892.00 thousand, reached on June 30, 2024.
Performance
PTGX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$2.90 M
-$296.00 K-9.28%
December 31, 2024
Summary
- As of March 12, 2025, PTGX TTM depreciation & amortization is $2.90 million, with the most recent change of -$296.00 thousand (-9.28%) on December 31, 2024.
- Over the past year, PTGX TTM D&A has dropped by -$296.00 thousand (-9.28%).
- PTGX TTM D&A is now -14.12% below its all-time high of $3.37 million, reached on June 30, 2024.
Performance
PTGX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
PTGX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.6% | -17.2% | -9.3% |
| 3 y3 years | +4.3% | -17.2% | -9.3% |
| 5 y5 years | +14.7% | -17.2% | -9.3% |
PTGX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.1% | +4.3% | -39.9% | at low | -14.1% | +4.3% |
| 5 y | 5-year | -14.1% | +14.7% | -39.9% | at low | -14.1% | +14.7% |
| alltime | all time | -14.1% | +1072.1% | -39.9% | +993.9% | -14.1% | +4891.4% |
Protagonist Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.90 M(-12.6%) | $536.00 K(-17.2%) | $2.90 M(-9.3%) |
| Sep 2024 | - | $647.00 K(-27.5%) | $3.19 M(-5.3%) |
| Jun 2024 | - | $892.00 K(+8.8%) | $3.37 M(+2.2%) |
| Mar 2024 | - | $820.00 K(-1.4%) | $3.30 M(-0.4%) |
| Dec 2023 | $3.31 M(-1.7%) | $832.00 K(+0.6%) | $3.31 M(-0.2%) |
| Sep 2023 | - | $827.00 K(+0.7%) | $3.32 M(-0.8%) |
| Jun 2023 | - | $821.00 K(-1.3%) | $3.35 M(-0.7%) |
| Mar 2023 | - | $832.00 K(-1.0%) | $3.37 M(-0.0%) |
| Dec 2022 | $3.37 M(+21.4%) | $840.00 K(-1.5%) | $3.37 M(+0.6%) |
| Sep 2022 | - | $853.00 K(+1.2%) | $3.35 M(+4.7%) |
| Jun 2022 | - | $843.00 K(+1.2%) | $3.20 M(+7.2%) |
| Mar 2022 | - | $833.00 K(+1.7%) | $2.98 M(+7.5%) |
| Dec 2021 | $2.77 M(+1.9%) | $819.00 K(+16.3%) | $2.77 M(+1.0%) |
| Sep 2021 | - | $704.00 K(+12.1%) | $2.75 M(+2.9%) |
| Jun 2021 | - | $628.00 K(+0.6%) | $2.67 M(-0.6%) |
| Mar 2021 | - | $624.00 K(-21.1%) | $2.69 M(-1.4%) |
| Dec 2020 | $2.72 M(+7.9%) | $791.00 K(+26.4%) | $2.72 M(+4.4%) |
| Sep 2020 | - | $626.00 K(-2.9%) | $2.61 M(-0.5%) |
| Jun 2020 | - | $645.00 K(-2.4%) | $2.62 M(+1.0%) |
| Mar 2020 | - | $661.00 K(-2.2%) | $2.60 M(+2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $2.52 M(+378.9%) | $676.00 K(+5.8%) | $2.52 M(+27.7%) |
| Sep 2019 | - | $639.00 K(+3.1%) | $1.98 M(+32.8%) |
| Jun 2019 | - | $620.00 K(+5.3%) | $1.49 M(+43.4%) |
| Mar 2019 | - | $589.00 K(+360.2%) | $1.04 M(+97.0%) |
| Dec 2018 | $527.00 K(+29.8%) | $128.00 K(-15.2%) | $527.00 K(+2.1%) |
| Sep 2018 | - | $151.00 K(-11.2%) | $516.00 K(+9.1%) |
| Jun 2018 | - | $170.00 K(+117.9%) | $473.00 K(+19.4%) |
| Mar 2018 | - | $78.00 K(-33.3%) | $396.00 K(-2.5%) |
| Dec 2017 | $406.00 K(+28.1%) | $117.00 K(+8.3%) | $406.00 K(+11.5%) |
| Sep 2017 | - | $108.00 K(+16.1%) | $364.00 K(+7.4%) |
| Jun 2017 | - | $93.00 K(+5.7%) | $339.00 K(+2.1%) |
| Mar 2017 | - | $88.00 K(+17.3%) | $332.00 K(+4.7%) |
| Dec 2016 | $317.00 K(+28.3%) | $75.00 K(-9.6%) | $317.00 K(-3.6%) |
| Sep 2016 | - | $83.00 K(-3.5%) | $329.00 K(+11.5%) |
| Jun 2016 | - | $86.00 K(+17.8%) | $295.00 K(+12.6%) |
| Mar 2016 | - | $73.00 K(-16.1%) | $262.00 K(+6.1%) |
| Dec 2015 | $247.00 K(-4.3%) | $87.00 K(+77.6%) | $247.00 K(+54.4%) |
| Sep 2015 | - | $49.00 K(-7.5%) | $160.00 K(+44.1%) |
| Jun 2015 | - | $53.00 K(-8.6%) | $111.00 K(+91.4%) |
| Mar 2015 | - | $58.00 K | $58.00 K |
| Dec 2014 | $258.00 K | - | - |
FAQ
- What is Protagonist Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual D&A year-on-year change?
- What is Protagonist Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly D&A year-on-year change?
- What is Protagonist Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM D&A year-on-year change?
What is Protagonist Therapeutics annual depreciation & amortization?
The current annual D&A of PTGX is $2.90 M
What is the all time high annual D&A for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual depreciation & amortization is $3.37 M
What is Protagonist Therapeutics annual D&A year-on-year change?
Over the past year, PTGX annual depreciation & amortization has changed by -$417.00 K (-12.59%)
What is Protagonist Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of PTGX is $536.00 K
What is the all time high quarterly D&A for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly depreciation & amortization is $892.00 K
What is Protagonist Therapeutics quarterly D&A year-on-year change?
Over the past year, PTGX quarterly depreciation & amortization has changed by -$111.00 K (-17.16%)
What is Protagonist Therapeutics TTM depreciation & amortization?
The current TTM D&A of PTGX is $2.90 M
What is the all time high TTM D&A for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM depreciation & amortization is $3.37 M
What is Protagonist Therapeutics TTM D&A year-on-year change?
Over the past year, PTGX TTM depreciation & amortization has changed by -$296.00 K (-9.28%)